Geneos Wealth Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,000	Closed	-$3.32K	–	2155
2023 Q3	$3.32K	Buy	+2,000	New	+$3.32K	﹤0.01%	1843